U.S. flag

An official website of the United States government

NM_000022.2(ADA):c.22G>A (p.Asp8Asn) AND Adenosine deaminase 2 allozyme

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 1, 2001
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002050.2

Allele description [Variation Report for NM_000022.2(ADA):c.22G>A (p.Asp8Asn)]

NM_000022.2(ADA):c.22G>A (p.Asp8Asn)

Genes:
LOC107303343:adenosine deaminase intronic regulatory elements [Gene]
ADA:adenosine deaminase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20q13.12
Genomic location:
Preferred name:
NM_000022.2(ADA):c.22G>A (p.Asp8Asn)
Other names:
NM_000022.2(ADA):c.22G>A
HGVS:
  • NC_000020.11:g.44651586C>T
  • NG_007385.1:g.5150G>A
  • NG_046759.1:g.22683C>T
  • NM_000022.4:c.22G>AMANE SELECT
  • NM_001322050.2:c.-268G>A
  • NM_001322051.2:c.22G>A
  • NP_000013.2:p.Asp8Asn
  • NP_001308980.1:p.Asp8Asn
  • LRG_16t1:c.22G>A
  • LRG_16:g.5150G>A
  • NC_000020.10:g.43280227C>T
  • NM_000022.2:c.22G>A
  • NR_136160.2:n.114G>A
  • P00813:p.Asp8Asn
Protein change:
D8N; ASP8ASN
Links:
UniProtKB: P00813#VAR_002209; OMIM: 608958.0021; dbSNP: rs73598374
NCBI 1000 Genomes Browser:
rs73598374
Molecular consequence:
  • NM_001322050.2:c.-268G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000022.4:c.22G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322051.2:c.22G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_136160.2:n.114G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Adenosine deaminase 2 allozyme
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022208OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 2001)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Autism: evidence of association with adenosine deaminase genetic polymorphism.

Bottini N, De Luca D, Saccucci P, Fiumara A, Elia M, Porfirio MC, Lucarelli P, Curatolo P.

Neurogenetics. 2001 Mar;3(2):111-3.

PubMed [citation]
PMID:
11354825

Details of each submission

From OMIM, SCV000022208.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Hirschhorn et al. (1994) determined that the common electrophoretic variant of ADA, the ADA2 allozyme (ADA*2), is caused by a 22G-A transition in the ADA gene, resulting in an asp8-to-asn (D8N) substitution. The ADA2 allozyme is a more basic electrophoretic variant that is codominantly inherited with the usual ADA1 allozyme. Functional expression studies of the D8N protein confirmed expression of an enzyme that comigrated with a naturally occurring ADA2 allozyme. Hirschhorn et al. (1994) noted that the ADA2 allozyme has been found in all populations studied and results in only minimally reduced enzyme activity in erythrocytes. The gene frequency of the ADA2 allozyme is estimated as 0.06 in Western populations, lower among individuals of African descent, and higher in Southeast Asian populations. The ADA2 allele was also found on at least 2 different genetic backgrounds, 1 of Ashkenazi Jewish ancestry and 1 in a large Mormon pedigree from Utah, suggesting independent recurrence of the mutation. Consistent with independent recurrence, the G-to-A transition was located in a CpG dinucleotide of the type subject to a high frequency of mutation. Hirschhorn et al. (1994) also found a probable intragenic crossover in the very large first intron that is rich in repetitive DNA sequences.

In 2 Italian groups of autistic children, Bottini et al. (2001) found a significantly higher frequency of the low-activity ADA2 allele than in controls. They suggested that this genotype-dependent reduction in ADA activity may be a risk factor for the development of autism.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024